Who are Luteal support with estrogen + progesterone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Estradiol + Progesterone, Human chorionic gonadotrophin, Conjugated equine estrogen topical cream, Change in daily dosage of Growth Hormone, Estradiol/norethindrone acetate, Gabapentin, Estrogen and placebo administration.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/luteal-support-with-estrogen-progesterone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Luteal support with estrogen + progesterone — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Luteal support with estrogen + progesterone (Luteal support with estrogen + progesterone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hormone replacement therapy. Area: Reproductive Medicine / Fertility.

marketed Hormone replacement therapy Progesterone receptor (PR) and estrogen receptor (ER) Reproductive Medicine / Fertility Small molecule Live · refreshed every 30 min

Target snapshot

Luteal support with estrogen + progesterone (Luteal support with estrogen + progesterone) — Rabin Medical Center. Estrogen and progesterone supplementation during the luteal phase supports endometrial development and maintains pregnancy viability in assisted reproductive cycles.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Luteal support with estrogen + progesterone TARGET	Luteal support with estrogen + progesterone	Rabin Medical Center	marketed	Hormone replacement therapy	Progesterone receptor (PR) and estrogen receptor (ER)
Estradiol + Progesterone	Estradiol + Progesterone	Productos Científicos S. A. de C. V.	marketed	Hormone replacement therapy / Oral contraceptive	Estrogen receptor alpha (ERα), Estrogen receptor beta (ERβ), Progesterone receptor (PR)
Human chorionic gonadotrophin	Human chorionic gonadotrophin	The University of Hong Kong	marketed	Gonadotropin; Hormone replacement therapy	Luteinizing hormone receptor (LHCG receptor)
Conjugated equine estrogen topical cream	Conjugated equine estrogen topical cream	University of Louisville	marketed	Topical hormone replacement therapy; estrogen	Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ)
Change in daily dosage of Growth Hormone	Change in daily dosage of Growth Hormone	Amsterdam UMC, location VUmc	marketed	Growth hormone replacement therapy	Growth hormone receptor (GHR)
Estradiol/norethindrone acetate	Estradiol/norethindrone acetate	Myovant Sciences GmbH	marketed	Hormone replacement therapy (HRT)	Estrogen receptor alpha and beta; progesterone receptor
Gabapentin, Estrogen and placebo administration	Gabapentin, Estrogen and placebo administration	University of Rochester	marketed	Combination therapy (gabapentinoid + hormone replacement therapy)	Voltage-gated calcium channel (alpha-2-delta subunit) for gabapentin; estrogen receptor for estrogen

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hormone replacement therapy class)

Rabin Medical Center · 2 drugs in this class
Faculdade de Medicina do ABC · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Luteal support with estrogen + progesterone — Competitive Intelligence Brief. https://druglandscape.com/ci/luteal-support-with-estrogen-progesterone. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab